Stonebridge Financial Planning Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-60
Closed -$4K 338
2021
Q4
$4K Hold
60
﹤0.01% 379
2021
Q3
$9K Sell
60
-380
-86% -$55.3K ﹤0.01% 352
2021
Q2
$69K Sell
440
-300
-41% -$48.6K 0.04% 184
2021
Q1
$135K Sell
740
-100
-12% -$23.2K 0.08% 135
2020
Q4
$168K Buy
840
+100
+14% +$20.3K 0.11% 117
2020
Q3
$164K Buy
740
+580
+363% +$123K 0.12% 103
2020
Q2
$33K Hold
160
0.03% 211
2020
Q1
$22K Buy
160
+100
+167% +$11.6K 0.02% 237
2019
Q4
$5K Buy
+60
New +$4.57K ﹤0.01% 328

Other funds holding TDOC

Stonebridge Financial Planning Group's TDOC Position: Q1 2022 in Review

Stonebridge Financial Planning Group sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 60 shares — an estimated $4K sold.

Stonebridge Financial Planning Group first reported a position in TDOC in Q4 2019 and held it in 9 quarters. The position peaked at $168K in Q4 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Stonebridge Financial Planning Group reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Stonebridge Financial Planning Group sold 60 Teladoc Health shares in Q1 2022, an estimated $4K.
  • Stonebridge Financial Planning Group first reported a position in Teladoc Health in Q4 2019 and held it in 9 quarters.
  • Stonebridge Financial Planning Group's Teladoc Health position peaked at $168K in Q4 2020.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Stonebridge Financial Planning Group's 13F filing for Q1 2022, filed 10 May 2022.